Merck and Co., Inc. ("Merck") has initiated a voluntary recall of two Hib vaccines. "Hib" is a vaccine that protects against a bacteria that causes meningitis, and is routinely administered to children. The Iowa Department of Public Health would like Iowans to be aware of three key points regarding this recall:
There is no need to revaccinate children who have received the recalled vaccine. The vaccine's efficacy in providing protection against this disease is unchanged.
No adverse reaction to the recalled vaccine has been reported in Iowa and the Centers for Disease Control and Prevention has reported no adverse reactions in the U.S. If an adverse reaction were to occur, it would be a local infection at the vaccine injection site and would occur within one week of vaccination.
Vaccine providers in Iowa are being notified. Providers known to have received the recalled vaccine are being personally contacted by IDPH.
About 1 million doses of the vaccine are being recalled because of quality assurance. The risk of a reaction to the recalled vaccine is extremely low and IDPH does not believe this situation presents a health threat to children. -IDPH Press Release
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
